1,297
Views
0
CrossRef citations to date
0
Altmetric
Mental Health

The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 492-505 | Received 05 Feb 2024, Accepted 05 Mar 2024, Published online: 31 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.